RACHEL HUDMAN: Open Payments
NPI 1871084087 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 42 payments from 20 companies in 2025. Trend: 2023 $725 · 2024 $286 · 2025 $858
Food & beverage: $758Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $155 |
| Incyte Corporation | 2 | $138 |
| Gilead Sciences, Inc. | 1 | $100 |
| Janssen Biotech, Inc. | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 1 | $41 |
| Geron Corporation | 2 | $36 |
| GENZYME CORPORATION | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| SOBI, INC | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
Products named: JAKAFI, Trodelvy, RYBREVANT, KISQALI, OPDIVO, SCEMBLIX, Fabhalta, RYTELO.
Industry payments across AR — which companies pay providers there.
